Our paper 20?years later: Inhaled nitric oxide for the acute respiratory distress syndrome—discovery, current understanding, and focussed targets of future applications

详细信息    查看全文

• 作者：R. Rossaint ; K. Lewandowski ; W. M. Zapol
• 关键词：Nitric oxide ; Acute respiratory distress syndrome ; Pulmonary arterial hypertension ; Selective vasodilation ; Arterial oxygenation
• 刊名：Intensive Care Medicine
• 出版年：2014
• 出版时间：November 2014
• 年：2014
• 卷：40
• 期：11
• 页码：1649-1658
• 全文大小：305 KB
• 参考文献：1. Rossaint R, Falke KJ, López F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328:399-05 CrossRef
  2. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-76 CrossRef
  3. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-26 CrossRef
  4. Ignarro LJ, Byrns RE, Buga GM, Woods KS (1987) Endothelium derived relaxing factor from pulmonary artery and vein possesses pharmacological and chemical properties that are identical to those of nitric oxide radical. Circ Res 61:866-79 CrossRef
  5. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-047 CrossRef
  6. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338:1173-174 CrossRef
  7. Wagner PD, Saltzman HA, West JB (1974) Measurement of continuous distributions of ventilation–perfusion ratios: theory. J Appl Physiol 36:588-99
  8. Evans JW, Wagner PD (1977) Limits on VA/Q distributions from analysis of experimental inert gas elimination. J Appl Physiol Respir Environ Exerc Physiol 42:889-98
  9. Pappert D, Busch T, Gerlach H, Lewandowski K, Radermacher P, Rossaint R (1995) Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 82:1507-511 CrossRef
  10. Rossaint R, Slama K, Steudel W, Gerlach H, Pappert D, Veit S, Falke K (1995) Effect of inhaled nitric oxide on right ventricular function in severe acute respiratory distress syndrome. Intensive Care Med 21:197-03 CrossRef
  11. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K, Hyers TM, Papadakos P (1998) Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled nitric oxide in ARDS study group. Crit Care Med 26:15-3 CrossRef
  12. Michael JR, Barton RG, Saffle JR, Mone M, Markewitz BA, Hillier K, Elstad MR, Campbell EJ, Troyer BE, Whatley RE, Liou TG, Samuelson WM, Carveth HJ, Hinson DM, Morris SE, Davis BL, Day RW (1998) Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 157:1372-380 CrossRef
  13. Troncy E, Collet JP, Shapiro S, Guimond JG, Blair L, Ducruet T, Francoeur M, Charbonneau M, Blaise G (1998) Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med 157:1483-488 CrossRef
  14. Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C (1999) Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 25:911-19 CrossRef
  15. Payen D, Vallet B, Group d’etude du NO dans l’ARDS (1999) Results of the French prospective multicentric randomized double-blind placebo-controlled trial on inhaled nitric oxide (NO) in ARDS [abstract]. Intensive Care Med 25(Suppl 1):S166
  16. Mehta S, Simms HH, Levy MM, Hill NS, Schwartz W, Nelson D, Short K, Klinger JR (2001) Inhaled nitric oxide improves oxygenation acutely but not chronically in acute respiratory distress syndrome: a randomized, controlled trial. J Appl Res 1:73-4
  17. Gerlach H, Keh D, Semmerow A, Busch T, Lewandowski K, Pappert DM, Rossaint R, Falke KJ (2003) Dose-response characteristics during long-term inhalation of nitric oxide in patients with severe acute respiratory distress syndrome: a prospective, randomized, controlled study. Am J Respir Crit Care Med 167:1008-015 CrossRef
  18. Park KJ, Lee YJ, Oh YJ, Lee KS, Sheen SS, Hwang SC (2003) Combined effects of inhaled nitric oxide and a recruitment maneuver in patients with acute respiratory distress syndrome. Yonsei Med J 44:219-26 CrossRef
  19. Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis K Jr, Kelly KM, Smith TC, Small RJ, Inhaled Nitric Oxide in ARDS Study Group (2004) Inhaled Nitric Oxide in ARDS Study Group: low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 291:1603-609 CrossRef
  20. Adhikari NKJ, Dellinger RP, Lundin S, Payen D, Vallet B, Gerlach H, Park KJ, Mehta S, Slutsky AS, Friedrich JO (2014) Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med 42:404-12 CrossRef
  21. Lee JM, Bae W, Lee YJ, Cho YJ (2014) The efficacy and safety of prone positional ventilation in acute respiratory distress syndrome: updated study-level meta-analysis of 11 randomized controlled trials. Crit Care Med 42:1252-262 CrossRef
  22. Okamoto K, Kukita I, Hamaguchi M, Motoyama T, Muranaka H, Harada T (2000) Combined effects of inhaled nitric oxide and positive end-expiratory pressure during mechanical ventilation in acute respiratory distress syndrome. Artif Organs 24:390-95 CrossRef
  23. Hoehn T, Krause MF (1998) Synergistic effects of high-frequency ventilation and inhaled nitric oxide in the treatment of hypoxemic respiratory failure in infancy. Pediatr Pulmonol 26:228-30 CrossRef
  24. Johannigman JA, Davis K, Miller SL, Campbell RS, Luchette FA, Frame SB, Branson RD (2001) Prone positioning and inhaled nitric oxide: synergistic therapies for acute respiratory distress syndrome. J Trauma 50:589-95 CrossRef
  25. Hartog A, Gommers D, van’t Veen A, Erdmann W, Lachmann B (1997) Exogenous surfactant and nitric oxide have a synergistic effect in improving gas exchange in experimental ARDS. Adv Exp Med Biol 428:277-79 CrossRef
  26. Zhu GF, Su B, Niu SF, Cai YY, Lin K, Lindwall R, Robertson B (1998) Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic-acid induced acute respiratory syndrome. Am J Respir Crit Care Med 158:437-43 CrossRef
  27. Net ARDS (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301-308 CrossRef
  28. Cheifetz IM, Hamel DS (2006) Is permissive hypoxemia a beneficial strategy for pediatric acute lung injury? Respir Care Clin N Am 12:359-69
  29. Gilbert-Kawai ET, Mitchell K, Martin D, Carlisle J, Grocott MP (2014) Permissive hypoxaemia versus normoxaemia for mechanically ventilated critically ill patients. Cochrane Database Syst Rev 7(5):CD009931
  30. MacIntyre NR (2013) Supporting oxygenation in acute respiratory failure. Respir Care 58:142-48 CrossRef
  31. Bigatello LM, Hurford WE, Kacmarek RM, Roberts JDJ, Zapol WM (1994) Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 80:761-70 CrossRef
  32. Gerlach H, Rossaint R, Pappert D, Falke KJ (1993) Time-course and dose response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23:499-02 CrossRef
  33. Lundin S, Westfelt UN, Stenqvist O, Frostell C (1996) Response to nitric oxide inhalation in early acute lung injury. Intensive Care Med 22:728-34 CrossRef
  34. Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:818-19 CrossRef
  35. Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:819-20 CrossRef
  36. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP (2000) Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342:469-74 CrossRef
  37. Roberts JD, Fineman JR, Morin FC 3rd, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336:605-10 CrossRef
  38. Subhedar N, Ryan S, Shaw N (1997) Open randomized controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed 77:F185–F190 CrossRef
  39. The Franco-Belgium Collaborative NO Trial Group (1999) Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomized controlled trial. Lancet 354:1066-071 CrossRef
  40. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, Abman SH (1999) Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomized controlled trial. Lancet 354:1061-065 CrossRef
  41. Srisuparp P, Heitschmidt M, Schreiber MD (2002) Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome. J Med Assoc Thai 85(suppl 2):S469–S478
  42. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P (2003) Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349:2099-107 CrossRef
  43. Field D, Elbourne D, Truesdale A, Diallo K, INNOVO Trial Collaborating Group (2005) Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomized controlled trial. Pediatrics 115:926-36 CrossRef
  44. Van Meurs K, Wright L, Ehrenkranz R, Lemons JA, Ball MB, Poole WK, Perritt R, Higgins RD, Oh W, Hudak ML, Laptook AR, Shankaran S, Finer NN, Carlo WA, Kennedy KA, Fridriksson JH, Steinhorn RH, Sokol GA, Konduri GG, Aschner JL, Stoll BJ, D’Angio CT, Stevenson DK, Preemie Inhaled Nitric Oxide Study (2005) Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 353:13-2 CrossRef
  45. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE, NO CLD Study Group (2006) Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355:343-53 CrossRef
  46. Dani C, Bertini G, Pezzati M, Filippi L, Cecchi A, Rubaltelli FF (2006) Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome. Acta Paediatr 95:1116-123 CrossRef
  47. Hascoet JM, Fresson J, Claris O, Hamon I, Lombet J, Liska A, Cantagrel S, Al Hosri J, Thiriez G, Valdes V, Vittu G, Egreteau L, Henrot A, Buchweiller MC, Onody P (2005) The safety and efficacy of nitric oxide therapy in premature infants. J Pediatr 146:318-23 CrossRef
  48. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH (2006) Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355:354-64 CrossRef
  49. Van Meurs KP, Hintz SR, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Das A, Higgins RD, Stevenson DK (2007) Inhaled nitric oxide in infants?<1500?g and?<34?weeks gestation with severe respiratory failure. J Perinatol 27:347-52 CrossRef
  50. Su PH, Chen JY (2008) Inhaled nitric oxide in the management of preterm infants with severe respiratory failure. J Perinatol 28:112-16 CrossRef
  51. Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, Baldassarre J, EUNO Study Group (2010) Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial. Lancet 376:346-54 CrossRef
  52. Barrington KJ, Finer N (2010) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 8(12):CD000509
  53. Askie LM, Ballard RA, Cutter GR, Dani C, Elbourne D, Field D (2011) Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics 128:729-39 CrossRef
  54. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D (1994) Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart disease. J Thorac Cardiovasc 107:1129-135
  55. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ (1994) Very low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 108:487-94
  56. Beghetti M, Habre W, Berner M (1995) Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 73:65-8 CrossRef
  57. Russell IA, Zwass MS, Fineman JR, Balea M, Rouine-Rapp K, Brook M, Hanley FL, Silverman NH, Cahalan MK (1998) The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease. Anesth Analg 87:46-1
  58. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, Celermajer DS (2000) Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomized double-blind study. Lancet 356:1464-469 CrossRef
  59. Day RW, Hawkins JA, McGough EC, Crezee KL, Orsmond GS (2000) Randomized controlled study of inhaled nitric oxide after operation for congenital heart surgery. Ann Thorac Surg 69:1907-913 CrossRef
  60. Morris K, Beghetti M, Petros A, Adatia I, Bohn D (2000) Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med 28:2974-978 CrossRef
  61. Bizzarro M, Gross I (2005) Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev 19(4):CD005055. doi:10.1002/14651858.CD005055
  62. Checchia PA, Bronicki RA, Goldstein B (2012) Review of inhaled nitric oxide in the pediatric cardiac surgery setting. Pediatr Cardiol 33:493-05 CrossRef
  63. Balzer DT, Kort HW, Day RW, Corneli HM, Kovalchin JP, Cannon BC (2002) Inhaled nitric oxide as a preoperative test (INOP Test I): the INOP Test Study Group. Circulation 106(12 Suppl 1):176-81
  64. Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE (1998) Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 114:780-86 CrossRef
  65. Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J (2001) Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 72:638-41 CrossRef
  66. Afshari?A, Brok J, M?ller AM, Wetterslev J (2010) Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) and acute lung injury in children and adults. Cochrane Database Syst Rev?7(7):CD002787
  67. Adhikari NKJ, Burns KEA, Friedrich JO, Granton JT, Cook DJ, Meade MO (2007) Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ 334:779-86 CrossRef
  68. Christenson J, Lavoi A, O’Connor M, Bhorade S, Pohlman A, Hall JB (2000) The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 161:1443-449 CrossRef
  69. Serirom S, Raharjo WH, Chotivanich K, Loareesuwan S, Kubes P, Ho M (2003) Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow. Am J Pathol 162:1651-660 CrossRef
  70. Bergmark B, Bergmark R, Beaudrap P, Boum Y, Mwanga-Amumpaire J, Ryan Carroll R, Zapol W (2012) Inhaled nitric oxide and cerebral malaria: basis of a strategy for buying time for pharmacotherapy. Pediatr Infect Dis J 31:e250–e254 CrossRef
  71. Hawkes M, Opoka RO, Namasopo S, Miller C, Thorpe KE, Lavery JV, Conroy AL, Liles WC, John CC, Kain KC (2011) Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials 12:176 CrossRef
  72. Evaluation of the efficacy and safety of inhaled nitric oxide as adjunctive treatment for cerebral malaria in children. Last updated 2013, Clinical Trials. Gov Identifier: NCT01388842
  73. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, Price RN, Duffull SB, Celermajer DS, Anstey NM (2008) Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci USA 105:17097-7102 CrossRef
  74. Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, Hawkes M, Krudsood S, Looareesuwan S, John CC, Liles WC, Kain KC (2009) Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS ONE 4:e4912 CrossRef
  75. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH (2008) Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358:1229-239 CrossRef
  76. Baron DM, Beloiartsev A, Nakagawa A, Martyn T, Stowell CP, Malhotra R, Mayeur C, Bloch KD, Zapol WM (2013) Adverse effects of hemorrhagic shock resuscitation with stored blood are ameliorated by inhaled nitric oxide in lambs. Crit Care Med 41:2492-501 CrossRef
  77. Gladwin MT, Kato GJ, Weiner D, Onyekwere OC, Dampier C, Hsu L, Hagar RW, Howard T, Nuss R, Okam MM, Tremonti CK, Berman B, Villella A, Krishnamurti L, Lanzkron S, Castro O, Gordeuk VR, Coles WA, Peters-Lawrence M, Nichols J, Hall MK, Hildesheim M, Blackwelder WC, Baldassarre J, Casella JF, DeNOVO Investigators (2011) Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 305:893-02 CrossRef
  78. Atz AM, Wessel DL (1997) Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology 87:988-90 CrossRef
  
• 作者单位：R. Rossaint (1)
  K. Lewandowski (2)
  W. M. Zapol (3)
  
  1. Klinik für An?sthesiologie, Universit?tsklinikum Aachen, Pauwelsstra?e 30, 52074, Aachen, Germany
  2. Klinik für An?sthesiologie, Intensivmedizin und Schmerztherapie, Elisabeth-Krankenhaus Essen, Klara-Kopp-Weg 1, 45138, Essen, Germany
  3. Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, 55 Fruit St., Boston, MA, 02114, USA
  
• ISSN：1432-1238

文摘

Introduction More than 20?years have passed since we reported our results of treating patients with the acute respiratory distress syndrome (ARDS) with inhaled nitric oxide (iNO). The main finding was that iNO alleviated pulmonary hypertension (PH) by selective vasodilation of pulmonary vessels in ventilated lung areas. This, in turn, improved arterial oxygenation. Methods We now set out to review the time span between the discovery of NO in 1987 and today in order to identify and describe interesting areas of research and clinical practice surrounding the application of iNO. Major Findings Enhancement of ventilation–perfusion matching and alleviation of PH in ARDS, treatment of PH of the newborn, and treatment of perioperative PH in congenital heart disease serve as just a few exciting examples for the successful use of iNO. Breathing NO prevents PH induced by stored blood transfusions or sickle cell disease. Exploiting the anti-inflammatory properties of NO helps to treat malaria. Discussion Regarding the use of iNO in ARDS, there remains the unresolved question of whether important outcome parameters can be positively influenced. At first glance, several randomized controlled trials and meta-analyses seem to send the clear message: “There is none!-Careful analyses, however, leave sufficient room for doubt that the ideal study to produce the unequivocal proof for the inability of iNO to positively impact on important outcome parameters has, as yet, not been conducted. Conclusion In summary, the discovery of and research on the many positive effects of iNO has improved care of critically ill patients worldwide. It is a noble effort to continue on this path.